Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -0.29% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -0.29% | ||||
| Cost of Revenue | -3.18% | ||||
| Gross Profit | 6.50% | ||||
| SG&A Expenses | -38.10% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -152.03% | ||||
| Total Operating Expenses | -2.12% | ||||
| Operating Income | 45.20% | ||||
| Income Before Tax | 132.33% | ||||
| Income Tax Expenses | -79.42% | ||||
| Earnings from Continuing Operations | 194.56% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 194.56% | ||||
| EBIT | 45.20% | ||||
| EBITDA | 115.66% | ||||
| EPS Basic | 194.78% | ||||
| Normalized Basic EPS | 122.22% | ||||
| EPS Diluted | 194.78% | ||||
| Normalized Diluted EPS | 122.22% | ||||
| Average Basic Shares Outstanding | 0.00% | ||||
| Average Diluted Shares Outstanding | 0.00% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||